Compare Enveric Biosciences Inc (ENVB) vs PDD Holdings Inc. American Depositary Shares (PDD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs PDD Holdings Inc. American Depositary Shares — how do they compare? Enveric Biosciences Inc trades at $1.51 (market cap $6.69M), while PDD Holdings Inc. American Depositary Shares trades at $79.09 (market cap $111.74B). The key difference: PDD Holdings Inc. American Depositary Shares is far larger — about 16702.5× Enveric Biosciences Inc's market cap, and Enveric Biosciences Inc is more actively traded (41,141 versus 4,029,869). Which is the better fit depends on your goals.
| ENVB | PDD | |
|---|---|---|
Market Cap | $6.69M | $111.74B |
Volume | 41,141 | 4,029,869 |
Sector | Health | Consumer Cyclical |
52-Week High | $10.80 | $138.13 |
52-Week Low | $1.27 | $73.30 |
Typical Hold Time | 14 Days | — |
Enterprise Value | -$1.60M | $44.39B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.495, up 1.7% on the day, but technical indicators signal a bearish trend with moving averages and ADX pointing lower. The company reported no revenue in 2025 and a net loss of $8.77 million, though it has consistently beaten EPS expectations. Recent news includes a new U.S. patent allowance for its non-hallucinogenic mescaline derivatives and participation in an investment conference.
The outlook remains speculative given the lack of revenue and negative profitability, but analyst consensus is bullish with 75% buy ratings. Key risks include the pre-revenue biotech model and dependence on successful drug development. Upside potential hinges on clinical progress and regulatory milestones for its psychiatric therapeutics pipeline.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About PDD Holdings Inc. American Depositary Shares
PDD Holdings is a multinational commerce group that owns and operates a portfolio of businesses. Its sourcing, logistics, and fulfillment network supports those businesses and their commerce operations.
Read more on PDD →
